Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEMETREXED vs PEMIGATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PEMETREXED vs PEMIGATINIB: Safety Overview

Metric PEMETREXED PEMIGATINIB
Total FAERS Reports 23,543 709
Deaths Reported 3,876 121
Death Rate 16.5% 17.1%
Hospitalizations 10,697 185
Average Patient Age 63.6 yrs 54.0 yrs
% Female Patients 41.0% 56.2%
FDA Approval Date Aug 18, 2022 Apr 17, 2020
Manufacturer BluePoint Laboratories Incyte Corporation
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription